thimerosal has been researched along with Grippe in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (43.75) | 29.6817 |
2010's | 7 (43.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buonomo, A; Carusi, V; Centrone, M; Chini, R; Franza, L; Newton, EE; Nucera, E; Pandolfi, F; Schiavino, D; Todi, L | 1 |
Chandrasekaran, V; Innis, BL; Jain, VK; Li, P; Liu, A; Wang, L | 1 |
Kondo, M; Shono, A | 1 |
Bennet, J; Brady, RC; Campbell, J; Cate, TR; Dekker, CL; Edwards, KM; Formica, N; Graham, I; Hartel, G; Ho, D; Keitel, W; Skeljo, M; Talbot, HK; Treanor, J; Walter, E; Winokur, P | 1 |
Ault, KA; del Rio, C; Halsey, NA; Omer, SB; Steinhoff, MC; Tamma, PD | 1 |
Basser, RL; Bennet, J; Hartel, GF; McVernon, J; Nolan, T; Richmond, PC; Skeljo, MV | 1 |
Schubert, C | 1 |
Descatha, A | 1 |
Hinman, AR; Orenstein, WA; Schuchat, A | 1 |
Abitbol, V; Benhamouda, N; Chauvat, A; Fridman, WH; Gey, A; Gougeon, ML; Launay, O; Levionnois, E; Loison, E; Marcheteau, E; Quintin-Colonna, F; Ravel, P; Roncelin, S; Tartour, E | 1 |
HOMMA, S; IWASAKI, K; NAGAKI, D; NAKASE, Y; UCHIYAMA, T | 1 |
HAGA, T; IWASAKI, K; NAGAKI, D; NAKASE, Y; UCHIYAMA, T | 1 |
Bridges, CB; Cox, NJ; Fukuda, K; Harper, SA; Uyeki, TM | 1 |
Bresee, JS; Cox, NJ; Shay, DK; Smith, NM; Strikas, RA; Uyeki, TM | 1 |
2 review(s) available for thimerosal and Grippe
Article | Year |
---|---|
The Importance of Complying with Vaccination Protocols in Developed Countries: "Anti-Vax" Hysteria and the Spread of Severe Preventable Diseases.
Topics: Autism Spectrum Disorder; Developed Countries; Guillain-Barre Syndrome; Humans; Influenza, Human; Preventive Medicine; Thimerosal; Vaccination; Vaccines | 2018 |
Safety of influenza vaccination during pregnancy.
Topics: Female; Humans; Infant, Newborn; Influenza Vaccines; Influenza, Human; Pregnancy; Pregnancy Complications, Infectious; Preservatives, Pharmaceutical; Safety; Thimerosal; Treatment Outcome | 2009 |
3 trial(s) available for thimerosal and Grippe
Article | Year |
---|---|
A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.
Topics: Adolescent; Adult; Drug Compounding; Female; Historically Controlled Study; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Thimerosal; Young Adult | 2014 |
Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.
Topics: Adult; Double-Blind Method; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Thimerosal; Vaccines, Inactivated; Young Adult | 2008 |
Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children.
Topics: Antibodies, Viral; Australia; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Excipients; Female; Fever; Hemagglutination Inhibition Tests; Humans; Immunization, Secondary; Infant; Influenza Vaccines; Influenza, Human; Male; Pain; Thimerosal; Vaccines, Inactivated | 2009 |
11 other study(ies) available for thimerosal and Grippe
Article | Year |
---|---|
Parents' preferences for seasonal influenza vaccine for their children in Japan.
Topics: Adult; Child; Choice Behavior; Female; Humans; Influenza Vaccines; Influenza, Human; Japan; Male; Middle Aged; Parents; Patient Preference; Preservatives, Pharmaceutical; Surveys and Questionnaires; Thimerosal; Vaccination; Vaccines, Attenuated; Young Adult | 2014 |
[Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].
Topics: Adjuvants, Immunologic; Child; Disease Outbreaks; Female; Germany; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mass Vaccination; Pharmacy and Therapeutics Committee; Pregnancy; Preservatives, Pharmaceutical; Product Surveillance, Postmarketing; Risk Factors; Thimerosal | 2009 |
Pandemic blows lid off laws limiting mercury in vaccines.
Topics: Disease Outbreaks; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Legislation, Drug; Preservatives, Pharmaceutical; Thimerosal; Vaccines | 2010 |
Unusual delayed reaction after H1N1 vaccine.
Topics: Dermatitis, Allergic Contact; Edema; Erythema; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Middle Aged; Skin Tests; Thimerosal; Vaccination | 2010 |
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011.
Topics: Advisory Committees; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; History, 20th Century; History, 21st Century; Humans; Immunization Programs; Infant; Infection Control; Influenza, Human; Information Systems; Measles; Pandemics; Periodicals as Topic; Preservatives, Pharmaceutical; Thimerosal; United States; Vaccines | 2011 |
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen.
Topics: Antigens, Viral; Cell Death; Cross Protection; Enzyme-Linked Immunospot Assay; False Positive Reactions; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Interferon-gamma; Leukocytes, Mononuclear; Lymphocyte Activation; Pandemics; T-Lymphocytes; Thimerosal; Vaccination | 2012 |
Studies on influenza virus. III. Studies on the influenza virus vaccine; immunization experiment of mice with the influenza virus vaccine inactivated by sodium ethylmercurithiosalicylate.
Topics: Animals; Humans; Immunization; Influenza Vaccines; Influenza, Human; Mice; Orthomyxoviridae; Salicylates; Thimerosal; Vaccination; Vaccines | 1953 |
Studies on influenza virus. IV. Studies on the influenza virus vaccine immunization experiment of man with influenza virus vaccine inactivated with sodium ethylmercurithiosalicylate.
Topics: Humans; Immunization; Influenza Vaccines; Influenza, Human; Male; Orthomyxoviridae; Salicylates; Thimerosal; Vaccination; Vaccines | 1954 |
More choices for avoiding the flu this winter.
Topics: Administration, Intranasal; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Influenza Vaccines; Influenza, Human; Mass Vaccination; Middle Aged; Pregnancy; Thimerosal; United States | 2003 |
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Female; Humans; Infant; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Pregnancy; Preservatives, Pharmaceutical; Thimerosal; United States; Vaccination; Vaccines, Attenuated; Vaccines, Inactivated | 2004 |
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Preservatives, Pharmaceutical; Thimerosal; Vaccines, Attenuated; Vaccines, Inactivated | 2006 |